Shih-Liang Hsiao

Title: Shih-Liang Hsiao: Innovator in Neurotensin Receptor Research

Introduction

Shih-Liang Hsiao is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies targeting neurotensin receptor 1 (NTSR1). His innovative work has implications for treating various diseases related to NTSR1 activity.

Latest Patents

Shih-Liang Hsiao holds a patent for "Humanized anti-human neurotensin receptor 1 antibodies and their uses." This patent describes a humanized anti-neurotensin receptor 1 (NTSR1) antibody or an antigen-binding fragment thereof. It also outlines methods for treating, prophylactic treating, and preventing diseases and disorders caused by or related to NTSR1 activity and signaling. Additionally, the patent includes a method or kit for detecting NTSR1 in a sample. He has 1 patent to his name.

Career Highlights

Throughout his career, Shih-Liang Hsiao has worked with notable organizations, including the Development Center for Biotechnology and the National Health Research Institutes. His work in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Shih-Liang Hsiao has collaborated with esteemed colleagues such as Cheng-Chou Yu and Shu-Ping Yeh. Their joint efforts have furthered research in the field of neurotensin receptor studies.

Conclusion

Shih-Liang Hsiao's innovative work in developing humanized antibodies for neurotensin receptor 1 showcases his dedication to advancing medical science. His contributions have the potential to impact the treatment of various disorders, highlighting the importance of research in biotechnology.